Found 19 matching trials
A Study of ONC201 for Refractory Meningioma
PHASE2The goal of this clinical trial is to learn about treatment for a type of b...
Location
Multiple Locations
Continuation of Oral ONC201 in Treating Patients With Advanced Solid Tumors
PHASE1This phase I trial studies the long-term side effects of the continuation o...
Location
Rutgers Cancer Institute of New Jersey
Oral ONC201 in Relapsed/Refractory Multiple Myeloma
PHASE1This was a Phase 1/2 open-label study of ONC201 administered orally once ev...
Location
The Mount Sinai Medical Center
Single Agent ONC201 in Recurrent or Metastatic Endometrial Cancer
PHASE2ONC201 is a small molecule which selectively targets the G protein-coupled ...
Location
Fox Chase Cancer Center
Expanded Access to ONC201 for Patients With H3 K27M-mutant and/or Midline High Grade Gliomas
N/AThe objective of this expanded access program is to provide ONC201 to eligi...
Status
No Longer Available
Akt/ERK Inhibitor ONC201 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
PHASE1This phase I/II trial studies the side effects and the best dose of v-akt m...
Location
M D Anderson Cancer Center
ONC201 Plus Weekly Paclitaxel in Patients With Platinum Refractory or Resistant Ovarian Cancer
PHASE2This phase II trial studies the side effects of ONC201 and paclitaxel and h...
Location
Barbara Ann Karmanos Cancer Institute
Expanded Access Use of ONC201 in a Patient With Diffuse Intrinsic Pontine Gliomas
N/AThis is an intermediate-size expanded access protocol to provide ONC201 to ...
Status
No Longer Available
Location
University of California San Francisco
ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer
PHASE1Endometrial cancer (EC) is the fourth most common cancer in United States w...
Location
Lineberger Comprehensive Cancer Center
Combination Therapy for the Treatment of Diffuse Midline Gliomas
PHASE2This phase II trial determines if the combination of ONC201 with different ...
Location
University of Alabama at Birmingham